Trial Profile
Dyslipidemia of Obesity Intervention in Teens Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jul 2023
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms DO-IT
- 28 Jun 2023 Status changed from active, no longer recruiting to completed.
- 20 Apr 2021 Status changed from recruiting to active, no longer recruiting.
- 12 Sep 2019 Planned End Date changed from 31 May 2022 to 30 Apr 2024.